CD8A and neoplasm: To further explore their function in mediating the enhanced anti-tumor immunity of ADAM17 deficient CD8+ T cells, we examined their expression in WT and ADAM17 deficient CD8+ TILs in the ACT tumor model (Fig. 3c).